Literature DB >> 26661227

Modifying blood-brain barrier transport to bring hope for patients with lysosomal storage diseases.

Richard F Keep1, Jianming Xiang2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26661227      PMCID： PMC4794100          DOI： 10.1177/0271678X15615358

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN： 0271-678X            Impact factor:   6.200


× No keyword cloud information.
  6 in total

1.  Pharmacologic manipulation of lysosomal enzyme transport across the blood-brain barrier.

Authors:  Akihiko Urayama; Jeffrey H Grubb; William S Sly; William A Banks
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-03       Impact factor: 6.200

2.  β2 Agonists enhance the efficacy of simultaneous enzyme replacement therapy in murine Pompe disease.

Authors:  Dwight D Koeberl; Songtao Li; Jian Dai; Beth L Thurberg; Deeksha Bali; Priya S Kishnani
Journal:  Mol Genet Metab       Date:  2011-11-11       Impact factor: 4.797

3.  Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier.

Authors:  Akihiko Urayama; Jeffrey H Grubb; William S Sly; William A Banks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

4.  Epinephrine enhances lysosomal enzyme delivery across the blood brain barrier by up-regulation of the mannose 6-phosphate receptor.

Authors:  Akihiko Urayama; Jeffrey H Grubb; William A Banks; William S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-23       Impact factor: 11.205

Review 5.  Delivery of therapeutic peptides and proteins to the CNS.

Authors:  Therese S Salameh; William A Banks
Journal:  Adv Pharmacol       Date:  2014-08-22

Review 6.  Lysosomal storage diseases: from pathophysiology to therapy.

Authors:  Giancarlo Parenti; Generoso Andria; Andrea Ballabio
Journal:  Annu Rev Med       Date:  2015       Impact factor: 13.739
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.